Home/ Supplements/ Niacin/ Non-Yeast GTF (Glucose Tolerance Factor)

Non-Yeast GTF (Glucose Tolerance Factor)

product on market Capsule Ecological Formulas Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Chromium and niacin are supported by moderate evidence for assisting in glucose metabolism and insulin sensitivity. The glutathione precursor complex provides antioxidants to support cellular health. Overall, research coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Non-Yeast GTF (Glucose Tolerance Factor)
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
120
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

15 mg (80% DV)
1.1× RDA — within safe limits 196 studies (A:5, B:63)
100 mcg (80% DV)
2.9× RDA — within safe limits 199 studies (A:1, B:55)
Glutathione Precursor Complex
125 mg

Other Ingredients

Cellulose Gelatin Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

For best results, NON-YEAST GTF should be taken on an empty stomach.

DIRECTIONS Take one to three capsules daily, one half hour before meals, or as directed by a physician.

Formulation Notes

This product contains no preservatives to ensure maximal tolerance and absorption.

Hypoallergenic

Additional Information

10080747

NON-YEAST GTF is a scientifically designed dietary supplement containing a highly bio-available form of trivalent chromium in solution with all other identified constituents of glucose tolerance factor.

The dosage of chromium reflect the elemental yield.

ECOLOGICAL FORMULAS

NON-YEAST GTF is well tolerated by exquisitely sensitive individuals for whom other sources of chromium are normally contraindicated. The nutrients are bound and do not occur in the free form.

EXP0813

Metadata

Product Details

DSLD Entry Date2013-06-25
Product TypeOther Combinations
FormCapsule
DSLD ID22897
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.